# A Clinical Trial to Evaluate the Food Effect of CKD-379

> **NCT06652971** · PHASE1 · COMPLETED · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 30 (actual)

## Conditions studied

- Type II Diabetes Mellitus

## Interventions

- **DRUG:** CKD-379

## Key facts

- **NCT ID:** NCT06652971
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-05
- **Primary completion:** 2024-12-04
- **Final completion:** 2024-12-17
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2024-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06652971

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06652971, "A Clinical Trial to Evaluate the Food Effect of CKD-379". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06652971. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*